Cormorant Private Healthcare Fund III LP (CIK 0001817320)

Latest company ownership

Role: 10% Owner
Shares held
3,570,872
Last filed at
Aug 1, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
Role: 10% Owner
Shares held
2,895,273
Last filed at
Apr 3, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
Shares held
1,994,173
Last filed at
Oct 1, 2025
Confidence Score
43.4
2025Q4
Confidence Score History
2023Q4 2025Q4
Shares held
1,404,953
Last filed at
Apr 1, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
Shares held
757,432
Last filed at
Sep 21, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
Shares held
723,177
Last filed at
Nov 23, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
Shares held
668,854
Last filed at
Oct 15, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q4 2025Q4
Shares held
477,857
Last filed at
Jun 30, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
237,015
Last filed at
Oct 27, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q4 2025Q4
Shares held
0
Last filed at
May 19, 2025
Confidence Score
47.7
2025Q4
Confidence Score History
2025Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 29, 2025 Oct 1, 2025 MoonLake Immunotherapeutics Other Sell 15.0 -6,499,978 -76.52% $46.9M
May 15, 2025 May 19, 2025 OnKure Therapeutics, Inc. Other Sell 17.5 -1,813,439 -100.00% $3.4M
May 12, 2025 May 14, 2025 OnKure Therapeutics, Inc. 10% Owner Sell 26.3 -24,300 -1.32% $48.2K
Apr 1, 2024 Apr 3, 2024 Immuneering Corp 10% Owner Sell 17.5 -400,000 -12.14% $1.2M
Mar 14, 2024 Mar 18, 2024 Immuneering Corp 10% Owner Sell 17.5 -909,091 -21.62% $2.7M
Oct 5, 2023 Oct 10, 2023 MoonLake Immunotherapeutics 10% Owner Buy 77.5 +58,839 0.70% $3.5M
Oct 2, 2023 Oct 4, 2023 MoonLake Immunotherapeutics 10% Owner Buy 95.0 +293,212 3.60% $16.8M
Mar 30, 2023 Apr 3, 2023 Biomea Fusion, Inc. 10% Owner Buy 100.0 +400,000 12.61% $12M
Oct 25, 2021 Oct 27, 2021 Ventyx Biosciences, Inc. 10% Owner Buy 100.0 +625,000 79.59% $10M
Oct 13, 2021 Oct 15, 2021 Pyxis Oncology, Inc. Other Buy 100.0 +450,000 67.28% $7.2M
Sep 17, 2021 Sep 21, 2021 Tyra Biosciences, Inc. Other Buy 100.0 +312,500 41.26% $5M
Aug 3, 2021 Aug 5, 2021 Immuneering Corp 10% Owner Buy 100.0 +550,000 32.30% $8.3M
Jun 28, 2021 Jun 30, 2021 Monte Rosa Therapeutics, Inc. 10% Owner Buy 100.0 +600,000 23.06% $11.4M
Apr 20, 2021 Apr 22, 2021 Biomea Fusion, Inc. 10% Owner Buy 100.0 +900,000 39.63% $15.3M
Mar 30, 2021 Apr 1, 2021 Design Therapeutics, Inc. Other Buy 100.0 +750,000 17.18% $15M
Nov 23, 2020 Nov 23, 2020 Olema Pharmaceuticals, Inc. 10% Owner Buy 100.0 +425,000 14.94% $8.1M